• A
  • |
  • A
  • Text size

Pharmaceutical Coverage and Spending

Listed below are Council on Medical Service (CMS) reports from June 1998 to the present related to pharmaceutical coverage and spending. The recommendations in these reports reflect the final actions of the AMA House of Delegates and are official AMA policy.

Pharmaceutical Costs
CMS Report 2, I-15

Emergency Prescription Drug Refills
CMS Report 3, I-15

Parity of Payment for Administering Biologic Medications
CMS Report 4, I-15

Coverage for Chronic Pain Management
CMS and CSAPH Joint Report 1, A-15

Availability of Veterans Affairs Pharmacy Benefit
CMS Report 2, A-10

Radiology Benefits Managers
CMS Report 5, I-09

Payment for Biologic and Pharmacologic Agents
CMS Report 3, I-08

Comparative Effectiveness Research
CMS Report 5, I-08

Cost Sharing Arrangements for Prescription Drugs
CMS Report 1, I-07

Maximum Allowable Cost of Prescription Medications
CMS Report 2, A-07

Health Plan Treatment of Specialty Pharmaceuticals
CMS Report 4, I-06

Health Insurance Coverage of Specialty Pharmaceuticals
CMS Report 2, I-05

Reducing Prescription Drug Prices
CMS Report 7, I-03

Health Plan Coverage of Prescription Drugs
CMS Report 6, A-03

Study of State Actions to Control Pharmaceutical Costs
CMS Report 2, A-02

Continuity of Physicians and Pharmaceuticals in Managed Care Organizations
CMS Report 8, A-02

Medicare Pharmaceutical Benefit
CMS Report 11, A-02

Pharmaceutical Spending in the United States
CMS Report 3, I-00

Costs and Benefits of Pharmaceutical Use in the United States
CMS Report 9, I-99

Pharmacy Benefit Risk Sharing by Physicians
CMS Report 12, I-99

Health Plan Coverage for Over-the-Counter Drugs
CMS Report 1, I-98

Outpatient Pharmaceutical Coverage for Medicare Beneficiaries
CMS Report 11, I-98